Young, J. R. et al. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT., 444–453 (2013). Lee-Felker, S. A. et al. Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma...
Mahmoud b - 《Egyptian Journal of Radiology & Nuclear Medicine》 被引量: 1发表: 2015年 Retrospective study of diagnosis and treatment of renal oncocytoma Enhanced CT is an effective diagnostic method in assistant examination, but it is difficult to differentiate clear cell carcinoma only from the ...
FULL PAPER British Journal of Cancer (2015) 113, 1581–1589 | doi: 10.1038/bjc.2015.379 Keywords: clear-cell renal cell carcinoma; interleukin-6; interleukin-6 receptor; prognostic biomarker; conditional survival; cancer-specific survival; organ-confined disease Prognostic value of interleukin-6 and...
Interleukin-6 (IL-6) is the major cytokine that induces transcriptional acute and chronic inflammation responses, and was recently incorporated as a recurrence prognostication signature for localised clear-cell renal cell carcinoma (ccRCC). As the progno
Renal tumors in childhood are variable in presentation, histology and clinical outcome. The vast majority of children with renal tumors are now successfully treated. The history and evolution of the multidisciplinary treatment effort required is described. This effort is a triumph of modern medicine an...
Interleukin-6 (IL-6) is the major cytokine that induces transcriptional acute and chronic inflammation responses, and was recently incorporated as a recurrence prognostication signature for localised clear-cell renal cell carcinoma (ccRCC). As the prognostic efficacy of initial risk factors may ebb dur...